InspireMD, Inc. (the "Company") (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S.

(the “Company”) (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...

MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received ...

Cerebral embolic protection (CEP) devices are designed to stop this debris reaching the brain, and they have been suggested as a solution to reduce stroke risk for TAVI patients. However, evidence ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a ...

BEDFORD, Mass., Jan. 28, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510 (k) ...

Imperative Care, Inc. today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s Zoom System, maki ...

Background Intracranial atherosclerotic disease (ICAD) significantly contributes to ischemic stroke, especially among Asian populations. Large vessel occlusion (LVO) due to underlying ICAD accounts ...

Venous thromboembolism often occurs in the legs and lungs, causing deep vein thrombosis and pulmonary embolism, respectively. Arterial embolism can prevent blood flow to the brain or heart, triggering ...

Anticoagulation Uncertainty in Embolic Stroke of Undetermined Source Patrice Wendling September 20, 2024 0 ...

A pulmonary embolism, or PE, is a potentially life-threatening medical condition. Here’s what you need to know about this lung condition, including what it is and its risk factors, types, symptoms and ...